Ładuje się......
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?
Immune thrombocytopenia resulting from antibody-mediated platelet destruction combined with impaired platelet production is a common cause of thrombocytopenia. The decision to treat newly diagnosed patients is based on several factors including ceasing hemorrhagic manifestations, increasing the plat...
Zapisane w:
| Wydane w: | Blood Adv |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society of Hematology
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737126/ https://ncbi.nlm.nih.gov/pubmed/29296878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009860 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|